I am delighted to announce our next zoom session that will be taking place at 7.30 pm London time on Wednesday, the 29th of June.
We will have the pleasure of listening to Professor Tom Foltynie who will talk to us about “Does the repurposing of diabetes drugs offer hope for Parkinson’s patients?”
Professor Tom Foltynie is Professor of Neurology in the Department of Clinical and Movement Neurosciences, UCL Institute of Neurology and Consultant Neurologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London. He is responsible for Movement disorder patients, particularly Parkinson’s disease (PD) patients undergoing advanced treatments such as Deep Brain Stimulation (DBS), Apomorphine and Duodopa. He is chief investigator for a series of trials of Exenatide- a potential neurorestorative treatment for PD, as well as the lead clinician at UCL for trials of alpha synuclein vaccination for PD and Oxford Biomedica/ Axovant’s gene therapy product for PD, and the Transeuro PD cell transplantation programme.
Please use the Eventbrite link below to register for this event:
